Summary

A summary of this response is provided as an interactive PDF (iPDF) that can be accessed by clicking the following link:

• DARZALEX^® (daratumumab) + DARZALEX FASPRO^® (daratumumab and hyaluronidase) Maintenance Use After Autologous Stem Cell Transplant.
  • Minimum requirement to access interactive content: Adobe Acrobat Reader
• The executive summary infographic of the iPDF content is provided below